Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023
/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the third quarter (Q3) and nine month (9M)...
Source: prnewswire.com